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Cutaneous lichen planus has been associated in
patients with chronic hepatitis C virus infection. It is
still unknown whether hepatitis C virus infects kera-
tinocytes of lichen planus lesions. In this report we
have analyzed the presence of genomic and anti-
genomic hepatitis C virus RNA in skin biopsies from
26 patients with chronic hepatitis C and healthy skin
and from 24 patients with cutaneous lichen planus
(®ve with and 19 without hepatitis C virus infection)
by in situ hybridization. Hepatitis C virus RNA was
detected in the keratinocytes of 69% of the patients
with healthy skin and chronic hepatitis C, in 100% of
the patients with lichen planus and hepatitis C virus
infection, and in none of lichen planus patients
without hepatitis C virus infection. The percentage
of keratinocytes showing genomic or anti-genomic
hepatitis C virus RNA was statistically lower (p < 0.01
in all cases) in patients with healthy skin (mean 6 SD:
5.7 6 3.5% and 2.7 6 3.1% of keratinocytes with
genomic or anti-genomic hepatitis C virus RNA,
respectively) than in those with lichen planus lesions
(31.7 6 7.9% and 18.8 6 7.4%, mean 6 SD) or the
unaffected adjacent skin (24.8 6 6.9% and 14.3 6
3.8%, mean 6 SD). In conclusion, we have demon-
strated that hepatitis C virus infects keratinocytes
from patients with lichen planus and hepatitis C virus
infection. Key words: hepatitis C virus-RNA/in situ
hybridization/skin. J Invest Dermatol 119:798±803, 2002
H
epatitis C virus (HCV) is a small-enveloped virus
belonging to the Flaviviridae family of animal
viruses. Its genome consists of a single-stranded
RNA of positive polarity and is about 9.4 kb in
length (Kato et al, 1990). As is the case with other
¯aviviruses, it is thought that HCV replicates through a RNA
intermediate of anti-genomic polarity (Clarke, 1997).
Chronic HCV infection causes a wide range of types of liver
damage, ranging from mild chronic hepatitis to liver cirrhosis and
hepatocellular carcinoma (Di Bisceglie, 1997); however, besides
liver disease, chronic HCV infection is associated with several
extrahepatic manifestations, with skin disorders frequently observed
in these patients (Hadziyannis, 1998; Doutre, 1999). In relation to
these skin diseases, several epidemiologic studies have shown that
lichen planus (LP) lesions are more prevalent in patients with
chronic hepatitis C than in the general population (Nagao et al,
1995; Carrozzo et al, 1996).
LP is a mucocutaneous disease of unknown etiology that may be
caused by a cell-mediated immune response directed against
induced antigenic changes in epidermal keratinocytes (Sugerman
et al, 2000). In a previous study, Mangia et al (1999), using the
reverse transcription±polymerase chain reaction (reverse transcrip-
tion±PCR), were unable to detect HCV-RNA of anti-genomic
polarity (as an indicator of HCV replication) in skin samples from
patients with LP and chronic hepatitis C. By contrast, Erkek et al
(2001) detected HCV-RNA by PCR in lesional skin biopsies from
patients with chronic HCV infection and LP. Furthermore, we
have recently reported that HCV infects oral mucosa epithelial cells
from patients with oral LP and chronic HCV infection (Arrieta et al,
2000). Thus, it must still be determined whether HCV infects
keratinocytes from LP lesions.
For these reasons, in this study, we present the results of an in situ
hybridization study on the presence of genomic and anti-genomic
HCV-RNA in skin biopsies from patients with cutaneous LP and
chronic hepatitis C compared with biopsies of healthy skin from
patients with chronic HCV infection.
PATIENTS AND METHODS
Patients The presence of HCV-RNA of genomic and anti-genomic
polarities was analyzed by in situ hybridization in paraf®n-embedded skin
biopsies from three groups of patients.
Group 1 Twenty-six patients (12 female/14 male; age: 42.54 6
12.38 y, mean 6 SD) with histologically proven chronic hepatitis C and
healthy skin without LP. All patients were anti-HCV positive, and
HCV-RNA was detectable in the serum of 23 of them. Seven patients
had normal alanine aminotransferase (ALT) values (upper normal limit
40 IU per liter), whereas the remaining 19 patients had abnormal ALT
levels (87.2 6 40.3 IU per liter, mean 6 SD).
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Group 2 Five patients (two female/three male; mean: 52 6 12.94 y,
mean 6 SD) with cutaneous LP and chronic HCV infection. HCV-
RNA was detectable in the serum of all ®ve patients but only one of
them was anti-HCV positive. Four of the ®ve patients had normal ALT
levels, whereas the other patient had abnormal ALT values (52 IU per
liter).
Group 3 Nineteen patients (10 female/nine male; age: 49.58 6
17.84 y, mean 6 SD) with cutaneous LP without markers of HCV
infection (anti-HCV and HCV-RNA negative in serum), and with
normal ALT values.
The inclusion criteria for patients from groups 2 and 3 were that there
would be suf®cient paraf®n-embedded tissue to perform the in situ
hybridization studies and that a serum sample obtained at the time of the
skin biopsy properly stored at ±20°C would be available.
None of the patients were receiving anti-viral or immunosuppressive
therapy when the skin biopsies were obtained. Other causes of liver
disease, such as autoimmune hepatitis, coinfection with other hepato-
tropic viruses, etc., were excluded. Furthermore, all the patients included
in this study were negative for the antibodies against the human
immunode®ciency virus (anti-human immunode®ciency virus).
Skin biopsies from LP lesions and from the unaffected adjacent skin
were obtained to con®rm the clinical diagnosis. After histologic examin-
ation, the remaining tissue was used for the in situ hybridization studies.
The anatomical locations of the LP lesions in patients with and without
chronic HCV infection are shown in Table I.
Skin samples from patients with healthy skin and chronic hepatitis C
were obtained when the diagnostic liver biopsy was performed. Liver
biopsies were obtained under ultrasonographic control and local anesthe-
sia. At the biopsy needle penetration site (between the eighth or ninth
intercostal space in the mid-axillary line), a 4 mm punch skin biopsy was
performed. Obtaining the skin biopsy did not modify the procedure used
to perform the liver biopsy.
The study was conducted in accordance with the guidelines of ``Good
Clinical Practice'' that underwrites the principles of the Declaration of
Helsinki on human experimentation. Written informed consent was
obtained from each patient participating in the study.
Serologic markers Anti-HCV was determined by a third-generation
enzyme-linked immunoassay (INNOTEST HCV AbIII, Innogenetics,
Heiden, Germany), and con®rmed by a recombinant immunoblot assay
(INNO-LIA HCV AbIII, Innogenetics).
Hepatitis B virus surface antigen, antibodies against hepatitis B virus
surface antigen, antibodies against hepatitis B core antigen, anti-hepatitis
D virus, IgM anti-hepatitis A virus, and anti-human immunode®ciency
virus were studied by commercial enzyme immunoassays (Roche
Diagnostic Systems, Basel, Switzerland).
HCV-RNA quanti®cation and genotyping in serum samples
HCV-RNA concentration in serum was determined using the Amplicor
HCV Monitor Quantitative Assay (Roche Diagnostics Systems). HCV
genotypes were determined with the INNO-LIPA HCV II test
(Innogenetics NV, Zwjnaarde, Belgium).
In situ hybridization Positive and negative polarity labeled HCV
riboprobes were generated by in vitro transcription of the pC5¢NCR
plasmid (that contains the cDNA corresponding to the complete 5¢
noncoding region of the HCV genome) in the presence of digoxigenin
11-uridine triphosphate (Roche Molecular Biochemicals, Indianapolis,
IN). Dewaxed sections of the skin biopsies were hybridized with positive
or negative polarity labeled probes to detect anti-genomic and genomic
HCV-RNA, respectively, as previously described (Arrieta et al, 2001).
The in situ hybridization speci®city was assessed by: (i) hybridization
with an unrelated probe (a 360 bp fragment of the chloramphenicol
acetyl transferase gene, generated by PCR and cloned in the pCRII-
TOPO vector); (ii) omission of the probe from the hybridization
mixture; and (iii) digestions of the sections with RNase A (0.2 mg per
ml) (Sigma, St Louis, MO) or DNase I (20 U per ml) (Sigma) for 2 h at
37°C prior to in situ hybridization.
The hybridization speci®city of the positive and negative polarity
riboprobes with their complementary HCV-RNA was assessed by dot
blot hybridization as described previously (Arrieta et al, 2001).
Immunohistochemistry Immunohistochemical detection of HCV
core antigen was performed in the skin biopsies from eight HCV-RNA-
positive and ®ve HCV-RNA-negative patients from whom enough
paraf®n-embedded tissue was available to perform this technique.
Detection of the HCV core antigen was automatically performed
(Tech Mate 500, Dako, Glostrup, Denmark) using an anti-HCV core
monoclonal antibody (Hepatitis C virus MonotopeTM, ViroStat,
Portland, ME) at a 1 : 30 dilution after antigenic retrieval pressure
cooking (3 min in 10 mM citrate buffer pH 6.0) using the Dako
Envision staining procedure. The detection speci®city of the HCV core
antigen was assessed by omitting the anti-HCV core antibody in the
immunohistochemical detection in serial sections of the same skin
biopsies.
As described above, immunohistochemical detection of the S-100
antigen (a marker of Langerhans dendritic cells) was also automatically
performed in the same tissue sections that were previously employed for
in situ hybridization using an anti-S-100 polyclonal antibody (Dako) at
1 : 2000 dilution.
Histologic diagnosis of LP lesions LP was histologically diagnosed
when there was basal cell damage, lymphohistiocytic in®ltrate in a band-
like pattern with variable intraepithelial exocytosis, and the presence of
homogeneous acidophilic bodies.
The severity of the in¯ammatory in®ltrate in hematoxylin±eosin-
stained skin sections was scored from 1 to 3, depending on the intensity:
1 When the interphase between the dermis and the epidermis was
preserved and the intensity of the in®ltrate was mild or focal in
distribution in the papillar dermis.
2 When the interphase between the dermis and the epidermis was
affected but had not disappeared, and the in®ltrate had a band-like
disposition of moderate intensity.
3 When the interphase had disappeared and the density of the in®ltrate
was severe.
Statistical analysis The Student's t test was used to analyze
quantitative data and the Spearman correlation test for correlation. All p-
values are two-tailed; p < 0.05 was considered to indicate statistical
signi®cance. All statistical analyses were performed using the SPSS
package (SPSS for Windows release 9.0, SPSS Inc., Chicago, IL).
RESULTS
HCV-RNA in serum In group 1 (chronic hepatitis C patients
with healthy skin), 23 of the 26 patients had HCV-RNA detectable
in serum. The viremia levels in these patients ranged from
9.5 3 103 IU per ml to 1.78 3 106 IU per ml (4.91 3 105 6
4.13 3 105 IU per ml, mean 6 SD).
In group 2 (patients with cutaneous LP and chronic HCV
infection), the ®ve patients had detectable HCV-RNA in their
serum at concentrations ranging from 103 IU per ml to 8.87 3 105
(1.79 3 105 6 3.95 3 105 IU per ml, mean 6 SD).
The fact that only one of the ®ve patients with cutaneous LP and
HCV-RNA in serum had anti-HCV antibodies could indicate that
these patients were immunosuppressed. All these patients, however,
were anti-human immunode®ciency virus negative and their
immunoglobulin levels and the leukocyte and lymphocyte counts
were within the normal ranges (Table II).
With respect to the HCV genotype, in group 1, 21 patients were
infected by HCV 1b, one patient by HCV 1a, and the remaining
patient was infected by the HCV 2a genotype. In group 2, the ®ve
patients were infected by the HCV 1b genotype.
Detection of HCV-RNA in keratinocytes by in situ
hybridization Positive hybridization signals were detected in
keratinocyte cytoplasm of the basal, spinous, and granular layers of
the epidermis in 18 of 26 (69.2%) of the skin biopsies from patients
with chronic hepatitis C and healthy skin (group 1) and in ®ve of
®ve (100%) of the patients with LP and chronic HCV infection
Table I. Histologic characteristics and location of
cutaneous LP lesions in the patients included in the study
Location of the lesions In®ltrate density
Arms Legs Trunk 1 2 3
Patients with chronic
hepatitis C (n = 5)
80% 80% 80% ± 40% 60%
Patients without
HCV infection (n = 19)
94.7% 84.2% 68.4% 5.3% 78.9% 15.8%
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(group 2) in both the LP lesions as well as in the unaffected adjacent
skin. No positive hybridization signals were observed in the skin
biopsies from the 19 anti-HCV-negative, serum HCV-RNA-
negative patients with cutaneous LP (group 3) (Fig 1).
The speci®city of the in situ hybridization was further con®rmed
by the lack of signals when the slides were hybridized with an
unrelated probe, when the probe was omitted from the hybridiza-
tion mix and when the slides were digested with RNase prior to
hybridization. In contrast, no changes were observed in the
hybridization patterns when the slides were predigested with
DNase (Fig 2).
Regarding the percentage of cells showing hybridization signals,
HCV-RNA of genomic polarity was observed in 5.7 6 3.5%
(mean 6 SD; range: 0.5±11.5%) of keratinocytes from patients
with healthy skin and in 31.7 6 7.9% (mean 6 SD; range: 20±
40%) and in 24.8 6 6.9% (mean 6 SD; range: 17±35%) of the
keratinocytes of LP lesions and the unaffected adjacent skin,
respectively, from the patients with cutaneous LP. The differences
in the percentages of keratinocytes showing genomic HCV-RNA
in healthy skin and in LP lesions and the unaffected adjacent skin
were statistically signi®cant (p = 0.001 and p = 0.003, respectively).
Similarly, the percentages of keratinocytes showing anti-genomic
HCV-RNA was signi®cantly lower (p = 0.007 and p = 0.001,
respectively) in patients with healthy skin (mean 6 SD:
2.7 6 3.1%; range: 0.4±13.2%) than in LP lesions (mean 6 SD:
18.8 6 7.4%; range: 15±32%), and than in the unaffected adjacent
skin (mean 6 SD: 14.3 6 3.8%; range 8±18%) (Table III).
The possibility of an unspeci®c hybridization between the
positive polarity probe and the genomic HCV-RNA and the
negative polarity probe and the anti-genomic viral RNA was
discarded as no unspeci®c hybridization was detected by dot-blot
hybridization (Fig 3).
No statistical correlation was found between the percentage of
keratinocytes showing HCV-RNA of genomic or anti-genomic
polarities and the HCV viremia in patients with healthy skin or
patients with LP.
Finally, no topologic correlation was observed between HCV-
infected keratinocytes and the in¯ammatory in®ltrate in the LP
lesions of the patients with chronic HCV infection.
Immunohistochemical detection of HCV core antigen and
colocalization of HCV-RNA by in situ hybridization and
the S-100 antigen by immunohistochemistry To con®rm
further that HCV infects and replicates in keratinocytes,
immunohistochemical detection of HCV core antigen was
performed in skin sections from patients with and without HCV-
RNA in serum. As shown in Fig 4, HCV core antigen was
detected in the keratinocyte cytoplasm from HCV-RNA positive
patients but not in the skin samples from the HCV-RNA negative
cases.
In order to con®rm that the HCV-infected cells were
keratinocytes and not dendritic (Langerhans) cells, immunohisto-
chemical detection of the S-100 antigen was performed on the
same slides used for the detection of HCV-RNA by in situ
hybridization. As shown in Fig 5, the cells expressing the S-100
antigen were different from those showing HCV-RNA.
Figure 1. Detection of genomic and anti-genomic HCV-RNA in
patients with and without cutaneous LP. Hybridization signals
corresponding to genomic HCV-RNA in LP lesions (a), unaffected
adjacent skin (c), and healthy skin (e). Detection of anti-genomic HCV-
RNA in LP lesions (b), unaffected adjacent skin (d), and healthy skin (f).
Lack of hybridization signals in a LP lesion (g) and in the unaffected
adjacent skin (h) from a patient without HCV infection. Counterstained
with safranine, original magni®cation (a±d,g) 3 200; (e,f,h) 3 400.
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1 Negative 920 200 80 0.05 6 3 106 40
2 Negative 860 145 70 0.09 9 3 106 45
3 Negative 1200 187 90 0.17 7 3 106 35
4 Negative 960 220 125 0.08 9 3 106 35
5 Positive 950 195 140 0.15 8 3 106 40
aNormal values: 800±1800 mg per 100 ml.
bNormal values: 90±400 mg per 100 ml.
cNormal values: 60±250 mg per 100 ml.
dNormal values: 0.01±0.43 mg per 100 ml.
eNormal values: 4.5±10 3106 cells per ml.
fNormal values: 20±50%.
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Histologic damage in patients with LP and with or without
HCV infection Regarding the intensity of the lymphocytic
in®ltrate in patients with LP with and without HCV infection,
three of ®ve (60%) patients with LP and HCV infection had an
in¯ammatory in®ltrate of intensity 3, whereas this occurred in three
of 19 (15.8%) patients with LP but without HCV infection. This
difference did not reach statistical signi®cance (Table I).
DISCUSSION
In this study we investigated the presence of HCV-RNA in
keratinocytes from patients with chronic HCV infection with and
without cutaneous LP.
HCV-RNA of genomic and anti-genomic polarities was
detected in the keratinocytes of 69% of patients with healthy skin
and chronic hepatitis C and in 100% of the patients with cutaneous
LP and chronic HCV infection. Viral infection of keratinocytes was
also con®rmed by the detection of HCV core antigen in skin
samples from patients with HCV-RNA in serum but not in the
skin biopsies from the HCV-RNA negative cases. Viral infection of
keratinocytes does not seem to be a special feature of HCV as it has
been shown that another hepatotropic virus, the hepatitis B virus, is
able to infect and replicate in keratinocytes (Mason et al, 1993).
Furthermore, it has been suggested that cytomegalovirus infection
of skin keratinocytes may be implicated in the development of skin
lesions in patients with systemic lupus erythematosus (Zhu, 1995)
Table III. Percentage of infected keratinocytes and serum viremia levels in the chronic hepatitis C patients with LP (1±5)
or with healthy skin (6±31)
Genomic HCV-RNA
(% of positive cells)
Anti-genomic HCV-RNA
(% of positive cells) HCV viremia
(IU per ml)
Patients with LP LP Adjacenta LP Adjacenta
1 40 17 32 15.4 8.87 3 105
2 31 28 16 8 9.29 3 103
3 20 22 15 13.5 1.2 3 103
4 38 35 16 16.5 103
5 29.5 22 15 18 103
Genomic HCV-RNA Anti-genomic HCV-RNA HCV viremia
Patients without LP (% of positive cells) (% of positive cells) (IU per ml)
6 0 0 2.55 3 105
7 0.5 0.7 8 3 105
8 0 0 ±
9 0.5 1 3 3 105
10 9 13.2 3.75 3 105
11 1 0.4 8.5 3 105
12 8 4 8.07 3 105
13 0% 0 ±
14 6 1 1.85 3 105
15 0 0 7.4 3 105
16 6.4 4.6 3.2 3 105
17 3.7 3 5.27 3 104
18 9 1 1.78 3 106
19 5 7.5 8.5 3 105
20 7 1 6.3 3 105
21 8 1 7.63 3 105
22 11.5 2.3 2.63 3 105
23 8.5 3 3.96 3 105
24 7.4 2.4 9.46 3 105
25 10 1 2 3 105
26 0.5 1 1.3 3 104
27 2 1.5 2.43 3 105
28 0 0 9.5 3 103
29 0 0 ±
30 0 0 1 3 105
31 0 0 4.92 3 104
aAdjacent unaffected skin.
Figure 2. Speci®city controls of the in situ hybridization
technique performed in different sections of the skin biopsy of
the lesion from a patient with LP and HCV-RNA in serum. (a)
DNase digestion and (b) RNase digestion (c) hybridization with the
unrelated labeled probe and (d) hybridization in the absence of the
HCV-labeled probe. Counterstained with saffranine, original
magni®cation: (a) 3 200; (b±d) 3 400.
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and Epstein±Barr virus infection of epithelial cells is associated with
the appearance of oral hairy leukoplakia (Greenspan et al, 1985).
The percentage of keratinocytes showing hybridization signals
corresponding to HCV-RNA of genomic and anti-genomic
polarities was signi®cantly higher in LP patients (in both the LP
lesion as well as in the unaffected adjacent skin) than in patients
with normal skin. As photoexposed skin is immunosuppressed
(Granstein, 1999), it may be argued that the differences observed in
the percentages of infected keratinocytes between patients with
healthy skin and patients with LP was due to the fact that the skin
biopsies from LP patients were obtained from a part of their body
that had been exposed to light. This is not the case, however, as not
only the skin samples from patients with healthy skin but also the
biopsies from LP patients were obtained from body zones that are
usually similarly photoexposed (the trunk in patients with healthy
skin, and legs, arms, or trunk in LP patients).
On the other hand, it could be argued that hybridization signals
are localized in the dendritic Langerhans cells and that they
correspond to HCV particles phagocyted by these cells. When
colocalization of HCV-RNA and the S-100 antigen were
performed, however, the corresponding signals were observed in
different cells.
Our results are in agreement with those reported by Erkek et al
(2001) who detected HCV-RNA in skin biopsies from LP lesions
in patients with chronic HCV infection; however, they differ from
those obtained by Mangia et al (1999) who did not detect HCV-
RNA of genomic and anti-genomic polarity using reverse
transcription±PCR in cutaneous LP lesions from patients with
chronic hepatitis C. The lack of detection of HCV-RNA by
reverse transcription±PCR in skin biopsies in the report by Mangia
et al may be explained by the time that elapsed between when the
skin biopsies were obtained and when they were frozen. Thus, it
has been reported that if liver biopsies are frozen in liquid nitrogen
5 min after they were obtained, HCV-RNA may be undetectable
by reverse transcription±PCR due to the partial degradation of the
viral RNA (MadejoÂn et al, 2000). In fact, this effect should be more
pronounced in skin biopsies than in liver biopsies, as the total
amount of HCV-RNA in skin samples should be lower than in
liver samples, in which up to 80% of hepatocytes may be infected
by the virus (Agnello et al, 1998; RodrõÂguez-InÄigo et al, 1999).
On the other hand, consistent with this study, in a previous
report it was demonstrated the presence of HCV-RNA of positive
and negative polarities in oral mucosa epithelial cells in oral LP
lesions from patients with chronic hepatitis C (Arrieta et al, 2000).
In that report, however, the percentage of infected oral mucosa
epithelial cells was similar in both the LP lesions and in healthy oral
mucosa, whereas in this study, as mentioned earlier, the proportion
of HCV-infected keratinocytes was signi®cantly higher in LP
Figure 4. Immunohistochemical detection of HCV core antigen
in the skin biopsies from an HCV-RNA positive patient (a) and
from a HCV-RNA negative case (b). Arrows indicate positively
stained keratinocytes.
Figure 5. Simultaneous detection of the S-100 antigen (open
arrows) and HCV-RNA (black arrows) in the LP lesion of a patient
with chronic hepatitis C. Original magni®cation 3 400.
Figure 3. Dot-blot hybridization of serial dilutions of synthetic
HCV-RNA of genomic and anti-genomic polarity with the HCV
anti-sense (a) and sense (b) probes.
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lesions than in healthy skin. We have no explanation for this
discrepancy, although it may be speculated that oral mucosa
epithelial cells produce different cellular factors that allow more
ef®cient HCV infection in oral mucosa epithelial cells than in
keratinocytes. This hypothesis requires testing in the future.
With respect to the implication of HCV infection of
keratinocytes in the development of cutaneous LP, the fact that
the percentage of HCV-infected keratinocytes was signi®cantly
higher in LP lesions than in healthy skin suggests that HCV
infection of keratinocytes may be involved in the pathogenesis of
cutaneous LP. The fact that the percentage of infected keratino-
cytes in LP lesions (31.7 6 7.9%) was very similar to that found in
the unaffected adjacent skin (24.8 6 6.9%), however, goes against
this hypothesis. Nevertheless, our ®ndings in LP patients suggest
that HCV infection of keratinocytes may contribute to the
development of LP lesions in patients with chronic HCV infection.
On the other hand, it is also possible that an unidenti®ed host factor
of patients with LP may facilitate the infection and propagation of
the virus in keratinocytes from these patients. In this sense, as only
one of the ®ve patients with LP and HCV infection had detectable
anti-HCV antibodies, it may be speculated that these patients may
have an immunologic defect that facilitates HCV infection of
keratinocytes. None of these patients, however, showed clinical or
analytical evidence of immunosuppression. Furthermore, in the
only patient with cutaneous LP and anti-HCV detectable in serum
the percentage of infected keratinocytes (40%) was similar to that
found in the four anti-HCV-negative cases (20±38%). Further
research is needed to establish whether the presence of circulating
anti-HCV in patients with LP does or does not modify the pattern
of HCV infection of keratinocytes.
On the other hand, it has been previously shown that HCV is
associated with very low-density lipoproteins in type II cryoglo-
bulins (Agnello, 1997) and that HCV may infect cells via the low-
density lipoprotein receptor (Agnello et al, 1999). As these receptors
are upregulated in keratinocytes from in¯ammatory skin lesions
(Agnello and Abel, 1997), the higher proportion of infected
keratinocytes observed in LP lesions compared with that in healthy
skin may be an epiphenomenon related to the greater expression of
low-density lipoprotein receptors in keratinocytes from cutaneous
LP lesions than in healthy skin. This hypothesis requires con®rm-
ation through the analysis of patients with chronic HCV infection
who also have other in¯ammatory skin diseases that are not
associated with the HCV infection, such as psoriasis.
With respect to the severity of LP lesions in patients with and
without HCV infection, in this study we have observed that,
whereas 60% of the patients with LP and chronic HCV infection
had a degree 3 in¯ammatory in®ltrate, this occurred in only 16% of
the patients with cutaneous LP without HCV infection. This
suggests that HCV infection of keratinocytes may increase the
severity of cutaneous LP lesions by a currently unidenti®ed
mechanism. This clearly warrants further investigation.
In conclusion, in this study we have demonstrated that HCV
infects keratinocytes from cutaneous LP lesions and that the viral
RNA is translated in these cells as demonstrated by the detection of
HCV core protein in the skin biopsies. Although, however, we
have detected HCV-RNA of negative polarity (which is usually
accepted as an indicator of HCV replication), we cannot af®rm that
HCV replicates in keratinocytes, as the negative polarity viral RNA
may be the result of an abortive transcription of the HCV-RNA.
So, further studies are needed to provide direct evidence of HCV
replication in keratinocytes. On the other hand, the percentage of
HCV-infected keratinocytes in patients with chronic hepatitis C
was signi®cantly higher in patients with cutaneous LP than in
patients with healthy skin. This ®nding suggests that HCV infection
of keratinocytes is involved in the pathogenesis of cutaneous LP in
patients with chronic HCV infection; however, more studies are
required to con®rm this hypothesis.
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